Chemoinformaics analysis of QUERCETIN-3-O-RHAMNODIGLUCOSIDE
| Molecular Weight | 772.662 | nRot | 9 |
| Heavy Atom Molecular Weight | 732.342 | nRig | 36 |
| Exact Molecular Weight | 772.206 | nRing | 6 |
| Solubility: LogS | -2.341 | nHRing | 4 |
| Solubility: LogP | -2.126 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 54 | No. of Aromatic Carbocycles | 2 |
| nHetero | 21 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 21 | No. of Arom Bond | 17 |
| nHA | 21 | APOL | 98.6237 |
| nHD | 13 | BPOL | 53.1483 |
| QED | 0.093 |
| Synth | 5.416 |
| Natural Product Likeliness | 1.604 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.989 |
| HIA | 0.992 |
| CACO-2 | -6.412 |
| MDCK | 0.000103391 |
| BBB | 0.222 |
| PPB | 0.793444 |
| VDSS | 0.584 |
| FU | 0.285153 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.01 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.214 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.124 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0 |
| CL | 0.802 |
| T12 | 0.405 |
| hERG | 0.023 |
| Ames | 0.599 |
| ROA | 0.036 |
| SkinSen | 0.017 |
| Carcinogencity | 0.054 |
| EI | 0.006 |
| Respiratory | 0.005 |
| NR-Aromatase | 0.887 |
| Antiviral | Yes |
| Prediction | 0.782761 |